Cargando…

Primary penile cancer organ sparing treatment

INTRODUCTION: Surgical treatment of penile cancer is usually associated with mutilation; alterations in self-esteem and body image; affecting sexual and urinary functions; and declined health-related quality of life. Recently, organ sparing treatment has appeared and led to limiting these complicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sosnowski, Roman, Kuligowski, Marcin, Kuczkiewicz, Olga, Moskal, Katarzyna, Wolski, Jan Karol, Bjurlin, Marc A., Wysock, James S., Pęczkowski, Piotr, Protzel, Chris, Demkow, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Urological Association 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260461/
https://www.ncbi.nlm.nih.gov/pubmed/28127454
http://dx.doi.org/10.5173/ceju.2016.890
Descripción
Sumario:INTRODUCTION: Surgical treatment of penile cancer is usually associated with mutilation; alterations in self-esteem and body image; affecting sexual and urinary functions; and declined health-related quality of life. Recently, organ sparing treatment has appeared and led to limiting these complications. MATERIAL AND METHODS: An extensive review of the literature concerning penile-preserving strategies was conducted. The focus was put on indications, general principles of management, surgical options and reconstructive techniques, the most common complications, as well as functional and oncological outcomes. RESULTS: Analyzed methods, e.g.: topical chemotherapy, laser ablation therapy, radiotherapy, Moh’s microscopic surgery, circumcision, wide local excision, glans resurfacing and glansectomy are indicated in low-stage tumors (Tis, Ta-T2). After glansectomy, reconstruction is also possible. CONCLUSIONS: Organ sparing techniques may achieve good anatomical, functional, and psychological outcomes without compromising local cancer control, which depends on early diagnosis and treatment. Penile sparing strategies are acceptable treatment approaches in selected patients with low-stage penile cancer after establishing disease-risk and should be considered in this population.